Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2013 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of benzodiazepines (BDZs) for panic disorder in adults, specifically: To determine the efficacy of BDZs in alleviating symptoms of panic disorder with or without agoraphobia in comparison to placebo; To review the acceptability of BDZs in panic disorder with or without agoraphobia in comparison with placebo; and To investigate the adverse effects of BDZs in panic disorder with or without agoraphobia, including the general prevalence of adverse effects, compared to placebo.

Original publication

DOI

10.1002/14651858.CD010677

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

31/07/2013

Volume

2013